Brief: H Lundbeck A/S Says Noted That Our Offer For Acquiring Avadel No Longer Is Considered Superior By Their Board, We Are Currently Considering Our Options
19/11/2025 14:23
Nov 19 (Reuters) - Alkermes Plc ALKS.O: H LUNDBECK A/S: NOTED THAT OUR OFFER FOR ACQUIRING AVADEL NO LONGER IS CONSIDERED SUPERIOR BY THEIR BOARD, WE ARE CURRENTLY CONSIDERING OUR OPTIONS Source text: [ID:] Further company coverage: ALKS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avadel Pharmaceuticals
See all newsBrief: Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 08:10 AM
H Lundbeck steps down from takeover for Avadel, shares rise 3%
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet